VITRO BIOPHARMA, INC.

Profile

Company Names

VITRO BIOPHARMA, INC.
VITRO DIAGNOSTICS INC

Addresses

4621 TECHNOLOGY DR., GOLDEN, CO 80403

3200 CHERRY CREEK DRIVE SOUTH, SUITE 410, DENVER, CO 80209

3200 CHERRY CREEK DRIVE SOUTH, SUITE 720, DENVER, CO 80209

4621 TECHNOLOGY DRIVE, GOLDEN, CO 80403

Phone Numbers

866-848-7627
8558487627
(855) 848-7627
303-999-2130

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER

Year Incorporated:

> 5 years ago

State Incorporated:

NEVADA

Total Amount Raised:

$7,210,100.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2025-05-27 
$100,000.00 
$15,000,000.00 
$14,900,000.00 
Equity 
6
2023-11-16 
$2,000,000.00 
$3,000,000.00 
$1,000,000.00 
Debt 
5
2023-01-06 
$992,600.00 
$2,500,000.00 
$1,507,400.00 
Debt 
4
2021-10-15 
$3,000,000.00 
$10,000,000.00 
$7,000,000.00 
Debt 
3
2020-01-15 
$1,000,000.00 
$3,500,000.00 
$2,500,000.00 
Equity 
2
2010-09-17 
$30,000.00 
$30,000.00 
$0.00 
Equity 
1
2009-12-18 
$87,500.00 
$87,500.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JOHN 
 
EVANS 
EXECUTIVE OFFICER, DIRECTOR
BEAM THERAPEUTICS INC.   |  VITRO DIAGNOSTICS INC   |  ACCUFIX HOLDINGS, INC.   |  VERVE THERAPEUTICS, INC.   |  PROMISING PEOPLE PLACEMENT, LLC
CHRIS 
 
FURMAN 
EXECUTIVE OFFICER, DIRECTOR
FDG HIVE SLC ASSOCIATES, LLC   |  FORUM INTEGRATED INCOME FUND I, L.P.   |  FREG KNOL HOLDINGS, LLC   |  VITRO BIOPHARMA, INC.
CHRISTOPHER 
 
FURMAN 
EXECUTIVE OFFICER, DIRECTOR
VITRO BIOPHARMA, INC.
NATHAN 
 
HAAS 
EXECUTIVE OFFICER
VITRO DIAGNOSTICS INC   |  VITRO BIOPHARMA, INC.
CAROLINE 
 
MOSESSIAN 
DIRECTOR, EXECUTIVE OFFICER
VITRO DIAGNOSTICS INC   |  VITRO BIOPHARMA, INC.
JAMES 
 
MUSICK 
DIRECTOR, EXECUTIVE OFFICER
VITRO DIAGNOSTICS INC   |  SOCIALPACK, INC.   |  VITRO BIOPHARMA, INC.
JAMES 
R 
MUSICK 
EXECUTIVE OFFICER, DIRECTOR
VITRO DIAGNOSTICS INC   |  VITRO BIOPHARMA, INC.
JAMES 
R. 
MUSICK 
EXECUTIVE OFFICER, DIRECTOR
VITRO BIOPHARMA, INC.
THOMAS 
 
OHRT 
EXECUTIVE OFFICER
PRE RESOURCES, INC.   |  VITRO BIOPHARMA, INC.
JOHN 
 
PACKS 
DIRECTOR
VITRO BIOPHARMA, INC.
TIANA 
 
STATES 
EXECUTIVE OFFICER
VITRO BIOPHARMA, INC.
ERIK 
 
VAN HORN 
DIRECTOR
VITRO DIAGNOSTICS INC
ERIK 
D. 
VAN HORN 
EXECUTIVE OFFICER, DIRECTOR
VITRO DIAGNOSTICS INC
JACK 
 
ZAMORA 
EXECUTIVE OFFICER, DIRECTOR
VITRO DIAGNOSTICS INC   |  ATTIVA U.S.A., INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-06-11
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2025-05-27 
2023-12-01
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2023-11-16 
2023-04-05
D/A
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2023-01-06 
2023-01-23
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2023-01-06 
2021-10-20
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2021-10-15 
2020-10-08
D/A
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2020-01-15 
2020-01-23
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2020-01-15 
2010-09-30
D
Link
OTHER 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2010-09-17 
2010-01-06
D
Link
OTHER 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1 - $1,000,000 
Equity 
2009-12-18 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#